Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

October 16, 2010

Ver artículo completo

Metformin Use and Mortality in Ambulatory Patients With Diabetes and Heart Failure

DADavid AguilarHeart Failure & Transplant WCWenyaw ChanThe University of Texas Health Science Center at Houston BBBiykem BozkurtAmerican College of Cardiology

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Metformin therapy was associated with lower rates of mortality in ambulatory patients with diabetes and HF. Future prospective studies are necessary to define the optimal therapy for diabetic patients with HF.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Metformin Use and Mortality in Ambulatory Patients With Diabetes and Heart Failure | Synapse

Cite This Study

Aguilar et al. (Sat,) studied this question.

synapsesocial.com/papers/69d7392af07a12db70b8a63b https://doi.org/https://doi.org/10.1161/circheartfailure.110.952556

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)1998 · 8,285 citations
2Phenformin-Associated Lactic Acidosis: Pathogenesis and Treatment1977 · 117 citations
3Metformin improves cardiac function in isolated streptozotocin-diabetic rat hearts1994 · 60 citations
4Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples2009 · 6,556 citations
5Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction2004 · 230 citations